Fact CheckerSign in

NCT06596226Active, not recruiting

Evaluating Pathways Mutual Gaze Protocol on Social Skills in Young Children Suspected of Autism

Evaluating The Efficacy of Pathways Parent-Mediated Intervention's Mutual Gaze Protocol on Social Skills in Young Children Suspected of Having Autism: A Randomized Control Trial

Source: ClinicalTrials.gov · Last updated 26 Jun 2026

Brief summary (registry, in English)

Purpose of the Study: The goal of this clinical trial is to find out if a technique called the "mutual gaze procedure," used in Pathways Early Intervention (Pathways), is the key to helping improve social communication, language, and everyday skills in young children (16-30 months old) who are at high risk for autism, particularly those from diverse cultural and language backgrounds. What Will Happen: Researchers will compare two versions of the Pathways Intervention: * Version 1: Includes mutual gaze strategies. * Version 2: Does not include mutual gaze strategies. What to Expect: Participants will: * Attend 12 sessions of Pathways Intervention, each lasting 1.5 hours (or 15 weeks if there are cancellations). * Come to the clinic for a developmental check-up three times: before starting Pathways, right after completing Pathways, and three months after finishing Pathways.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
80 (estimated)
First submitted
21 Aug 2024
Start date
10 Sept 2024
Primary completion date
15 Oct 2026
Lead sponsor
The University of Texas at Dallas
Diseases
Autism
NCT number
NCT06596226

What you commit to

  • Study type: Interventional
  • Planned participants: 80
  • From 10 Sept 2024 to the primary completion date, 15 Oct 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Children whose parents report they have any other known neurological or genetic concerns or disorders;

Age

  • Children younger than 16 months or older than 30 months at the start of the study

Other

  • Children who are not at high risk for autism based on an EarliPointTM assessment (with researcher confirmation of social challenges)
  • Children whose parents are not fluent in English or Spanish

Who the study is looking for

  • Children must be between 16-30 months old at the start of the study;
  • Children must receive social disability index of 7 or lower if child is 16-20 months old, or 8.1 or lower if child is 21-30 months old on the EarliPointTM assessment with a researcher (i.e., human) confirming social challenges are present;
  • Parents must report no other known neurological or genetic concerns or disorders
  • Parents must be fluent in English or Spanish
  • Parents must live within a 30-mile radius of the Callier Center Dallas or Callier Center Richardson.

Age in the registry: 16 months to 30 months · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Texas at Dallas
Coordinator of this site? Confirm its status
RichardsonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.